Metagenomi (MGX) Earnings Date & Reports

Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

MGX is expected to report earnings to rise 102.70% to -75 cents per share on May 20

Q1'25

Est.

$-0.75

Q4'24

Beat

by $0.40

Q3'24

Beat

by $0.24

Q2'24

Beat

by $0.41

Q4'23

Missed

by $3.63

The last earnings report on March 17 showed earnings per share of -37 cents, beating the estimate of -76 cents. With 240.09K shares outstanding, the current market capitalization sits at 55.33M.

View a ticker or compare two or three

Compare

MGX